Accelerate Diagnostics reported $-9797000 in Equity Capital and Reserves for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Accelerate Diagnostics AXDX:US USD -9797000 52.17M
Becton, Dickinson and BDX:US USD 25.3B 192M
Bio Rad Laboratories BIO:US USD 8.45B 468.99M
Bruker BRKR:US USD 937M 33.5M
Danaher DHR:US USD 46.98B 391M
Exact Sciences EXAS:US USD 3.11B 100.71M
Hologic HOLX:US USD 4.88B 121.7M
Illumina ILMN:US USD 6.73B 3.71B
Meridian Bioscience VIVO:US USD 368.06M 2.51M
Myriad Genetics MYGN:US USD 916.6M 30.8M
Nanostring Technologies NSTG:US USD 82.93M 29.74M
Pacific Biosciences Of California PACB:US USD 626.59M 55.29M
Quidel QDEL:US USD 4.8B 124.3M
Thermo Fisher Scientific TMO:US USD 43.61B 1.32B